Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Clinical Therapeutics
|
June 12, 2022
The Impact of Mandatory Nonmedical Switching From Originator to Biosimilar Insulin Glargine
Anat Fisher, Jason D Kim, Colin Dormuth
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 27, 2002
Pharmaceutical cost containment with reference-based pricing: time for refinements
Sebastian Schneeweiss, Malcolm Maclure, Colin Dormuth, et al.
Pharmacoepidemiology and Drug Safety
|
May 17, 2019
A theoretical exploration of therapeutic monomania as a physician-based instrumental variable
Brian J Potter, Colin Dormuth, Jacques Le Lorier
BMC Rheumatology
|
January 27, 2022
Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept-a cohort study in British Columbia
Anat Fisher, Jason D Kim, Greg Carney, et al.
The Cochrane Database of Systematic Reviews
|
September 5, 2020
Time course for blood pressure lowering of beta-blockers with partial agonist activity
Xiao-Yin Zhang, Sam Soufi, Colin Dormuth, et al.
Journal of General Internal Medicine
|
October 16, 2024
Changes in Sedative Use in British Columbia, Canada from 2012 to 2021: A Drug Utilization Study
Wade Thompson, Jason D Kim, Greg Carney, et al.
The Cochrane Database of Systematic Reviews
|
September 1, 2014
Time course for blood pressure lowering of dihydropyridine calcium channel blockers
Niousha Ghamami, Sandy Hsiang Yu Chiang, Colin Dormuth, et al.
Medical Care
|
June 24, 2004
Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents
Sebastian Schneeweiss, Colin Dormuth, Paul Grootendorst, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
February 28, 2007
Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients
Sebastian Schneeweiss, Soko Setoguchi, Alan Brookhart, et al.
BMJ Open
|
March 17, 2026
Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning-based cohort study
Greg Carney, Sean Burnett, Anshula Ambasta, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Clinical Therapeutics
|
June 12, 2022
The Impact of Mandatory Nonmedical Switching From Originator to Biosimilar Insulin Glargine
Anat Fisher, Jason D Kim, Colin Dormuth
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 27, 2002
Pharmaceutical cost containment with reference-based pricing: time for refinements
Sebastian Schneeweiss, Malcolm Maclure, Colin Dormuth, et al.
Pharmacoepidemiology and Drug Safety
|
May 17, 2019
A theoretical exploration of therapeutic monomania as a physician-based instrumental variable
Brian J Potter, Colin Dormuth, Jacques Le Lorier
BMC Rheumatology
|
January 27, 2022
Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept-a cohort study in British Columbia
Anat Fisher, Jason D Kim, Greg Carney, et al.
The Cochrane Database of Systematic Reviews
|
September 5, 2020
Time course for blood pressure lowering of beta-blockers with partial agonist activity
Xiao-Yin Zhang, Sam Soufi, Colin Dormuth, et al.
Journal of General Internal Medicine
|
October 16, 2024
Changes in Sedative Use in British Columbia, Canada from 2012 to 2021: A Drug Utilization Study
Wade Thompson, Jason D Kim, Greg Carney, et al.
The Cochrane Database of Systematic Reviews
|
September 1, 2014
Time course for blood pressure lowering of dihydropyridine calcium channel blockers
Niousha Ghamami, Sandy Hsiang Yu Chiang, Colin Dormuth, et al.
Medical Care
|
June 24, 2004
Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents
Sebastian Schneeweiss, Colin Dormuth, Paul Grootendorst, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
February 28, 2007
Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients
Sebastian Schneeweiss, Soko Setoguchi, Alan Brookhart, et al.
BMJ Open
|
March 17, 2026
Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning-based cohort study
Greg Carney, Sean Burnett, Anshula Ambasta, et al.
Page
of 4